Alexandria Real Estate (ARE) and Healthpeak (DOC) on Torvanta's measures: ARE grades higher on 0 of the 4 factor families and DOC on 3.
| ARE | DOC | |
|---|---|---|
| Value grade | n/a | C |
| Growth grade | D- | C |
| Profitability grade | C- | C- |
| Momentum grade | F | C- |
| Market value | $7.3B | $13.1B |
| P/E (trailing) | n/a | 54.2x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $2.8B | $2.9B |
| Revenue growth (y/y) | -8% | +6% |
| Operating margin | n/a | n/a |
| Return on invested capital | n/a | n/a |
| Free-cash-flow yield | 17.6% | 9.4% |
| Total return, 1 year | -41.3% | +9.8% |
| Total return, 3 years | -51.5% | +31.5% |
Full ARE analysis · Full DOC analysis
Alexandria Real Estate (ARE) and Healthpeak (DOC) on Torvanta's measures: ARE grades higher on 0 of the 4 factor families and DOC on 3. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings ARE trades at n/a and DOC at 54.2x; their value grades are n/a and C against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer